Responsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and chronic bronchitis

被引:23
|
作者
Monz, Brigitta U. [1 ]
Sachs, Paul [2 ,3 ]
McDonald, Jeffrey [4 ]
Crawford, Bruce [5 ]
Nivens, Michael C. [6 ]
Tetzlaff, Kay [6 ,7 ]
机构
[1] Boehringer Ingelhelm GmbH, D-55216 Ingelheim, Germany
[2] Stamford Hosp, Stamford, CT 06902 USA
[3] Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA
[4] Mapi Values, Boston, MA 02114 USA
[5] Mapi Values, Tokyo 1530064, Japan
[6] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA
[7] Univ Tubingen, Dept Sports Med, Med Clin, D-72076 Tubingen, Germany
关键词
Cough and sputum assessment questionnaire; COPD; Chronic bronchitis; Exacerbations; Responsiveness; OBSTRUCTIVE PULMONARY-DISEASE; SMOKING-CESSATION; TIME-COURSE; BREATHLESSNESS; VALIDATION; MANAGEMENT; RECOVERY; SYMPTOMS;
D O I
10.1016/j.rmed.2009.10.026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: To assess the responsiveness of the Cough and Sputum Assessment Questionnaire (CASA-Q) in COPD and chronic bronchitis patients recovering from an acute exacerbation. The 20-item questionnaire with a 7-day recall assesses the frequency and severity of cough and sputum and their impact on everyday life in clinical (trial) settings. The four domains (cough/sputum symptom and impact) use scales from 0 to 100, with lower scores indicating higher symptom/impact levels. Methods: Outpatients were enrolled within 48 h of symptom onset of their exacerbation. Treatment was initiated at the discretion of the investigator, and patients observed for 6 weeks. During study visits, 59 eligible patients completed the CASA-Q at enrolment, week 1, 2 and 6. Responsiveness was assessed by calculating standardized effect sizes. Results: Of the 19 male and 40 female patients with a mean (standard deviation, SD) age of 61.1 (10.5) years, all were classified by their physician to have improved or recovered after six weeks. The mean (SD) CASA-Qsores for the cough symptom, cough impact, sputum symptom and sputum impact domains increased from 32.6 (21.0), 40.7 (22.4), 37.4 (20.1), 47.1 (24.2) at enrolment to 54.0 (19.8), 63.7 (21.3), 55.1 (19.0), 65.5 (20.5) at week 6, respectively. Standardized effect sizes for patients improved or recovered from their exacerbation at week 6 were above 1.0 for the cough domains and at least 0.77 for the sputum domains. Conclusions: The CASA-Q was responsive to symptom changes in patients recovering from an exacerbation. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:534 / 541
页数:8
相关论文
共 50 条
  • [41] Inflammatory Biomarkers in Sputum Predict COPD Exacerbations
    Ellen Tufvesson
    Marie Ekberg
    Leif Bjermer
    Lung, 2013, 191 : 413 - 416
  • [42] Inflammatory Biomarkers in Sputum Predict COPD Exacerbations
    Tufvesson, Ellen
    Ekberg, Marie
    Bjermer, Leif
    LUNG, 2013, 191 (04) : 413 - 416
  • [43] Induced sputum markers during COPD exacerbations
    Bhowmik, A
    Seemungal, T
    Sapsford, RJ
    Devalia, JL
    Wedzicha, JA
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A449 - A449
  • [44] Safety of sputum induction during exacerbations of COPD
    Bathoorn, Erik
    Liesker, Jeroen
    Postma, Dirkje
    Koeter, Gerard
    van Oosterhout, Antoon J. M.
    Kerstjens, Huib A. M.
    CHEST, 2007, 131 (02) : 432 - 438
  • [45] ERYTHROMYCIN AND BROMHEXINE IN ACUTE EXACERBATIONS OF CHRONIC-BRONCHITIS - A STUDY ON SPUTUM PENETRATION AND CLINICAL EFFECTIVENESS
    MAESEN, FPV
    DAVIES, BI
    BROUWERS, J
    RUBINGH, G
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1982, 63 (04): : 325 - 329
  • [46] Infective exacerbations of chronic mucopurulent bronchitis: Relation between sputum bacteriology and lung function.
    Eller, J
    Ede, A
    Schaberg, T
    Lode, H
    CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 339 - 339
  • [47] Induced Sputum In Chronic Cough
    Lukan, N.
    Racz, O.
    Pullmann, R.
    Petrovicova, J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S8 - S8
  • [48] The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition
    Kim, Victor
    Zhao, Huaqing
    Regan, Elizabeth
    Han, MeiLan K.
    Make, Barry
    Crapo, James D.
    Jones, Paul W.
    Curtis, Jeffrey L.
    Silverman, Edwin K.
    Criner, Gerard J.
    Make, Barry J.
    Regan, Elizabeth A.
    Beaty, Terri
    Begum, Ferdouse
    Busch, Robert
    Castaldi, Peter J.
    Cho, Michael
    DeMeo, Dawn L.
    Boueiz, Adel R.
    Foreman, Marilyn G.
    Halper-Stromberg, Eitan
    Hansel, Nadia N.
    Hardin, Megan E.
    Hayden, Lystra P.
    Hersh, Craig P.
    Hetmanski, Jacqueline
    Hobbs, Brian D.
    Hokanson, John E.
    Laird, Nan
    Lange, Christoph
    Lutz, Sharon M.
    McDonald, Merry-Lynn
    Parker, Margaret M.
    Qiao, Dandi
    Santorico, Stephanie
    Wan, Emily S.
    Won, Sungho
    Charbonnier, Jean-Paul
    Coxson, Harvey O.
    Hoffman, Eric A.
    Humphries, Stephen
    Jacobson, Francine L.
    Judy, Philip F.
    Kazerooni, Ella A.
    Kluiber, Alex
    Lynch, David A.
    Newell, John D., Jr.
    Ross, James C.
    Estepar, Raul San Jose
    Sieren, Jered
    CHEST, 2019, 156 (04) : 685 - 695
  • [49] Domiciliary Cough Monitoring for the Prediction of COPD Exacerbations
    Michael G. Crooks
    Albertus C. den Brinker
    Susannah Thackray-Nocera
    Ralph van Dinther
    Caroline E. Wright
    Alyn H. Morice
    Lung, 2021, 199 : 131 - 137
  • [50] Chronic bronchitis, COPD
    Wirtz, H
    INTERNIST, 2005, 46 (02): : 175 - 191